Your browser doesn't support javascript.
loading
Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.
Millan, Mark J; Dekeyne, Anne; Gobert, Alain; Brocco, Mauricette; Mannoury la Cour, Clotilde; Ortuno, Jean-Claude; Watson, David; Fone, Kevin C F.
Afiliação
  • Millan MJ; Centre for Therapeutic Innovation in Neuropsychiatry, Institut de Recherche Servier, 78290, Croissy sur Seine, France. Electronic address: mark.millan@servier.com.
  • Dekeyne A; Centre for Therapeutic Innovation in Neuropsychiatry, Institut de Recherche Servier, 78290, Croissy sur Seine, France.
  • Gobert A; Centre for Therapeutic Innovation in Neuropsychiatry, Institut de Recherche Servier, 78290, Croissy sur Seine, France.
  • Brocco M; Centre for Therapeutic Innovation in Neuropsychiatry, Institut de Recherche Servier, 78290, Croissy sur Seine, France.
  • Mannoury la Cour C; Centre for Therapeutic Innovation in Neuropsychiatry, Institut de Recherche Servier, 78290, Croissy sur Seine, France.
  • Ortuno JC; Centre for Excellence in Chemistry, Institut de Recherche Servier, 78290, Croissy sur Seine, France.
  • Watson D; School of Life Sciences, Queen's Medical Centre, The University of Nottingham, NG7 2UH, England, UK.
  • Fone KCF; School of Life Sciences, Queen's Medical Centre, The University of Nottingham, NG7 2UH, England, UK.
Neuropharmacology ; 177: 108099, 2020 10 15.
Article em En | MEDLINE | ID: mdl-32525060

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Serotonina / Receptores de Dopamina D3 / Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Serotonina / Receptores de Dopamina D3 / Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2020 Tipo de documento: Article